Status:
NO_LONGER_AVAILABLE
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Lead Sponsor:
University of Iowa
Conditions:
Macular Degeneration
Eligibility:
All Genders
55+ years
Brief Summary
The purpose of this study is to evaluate whether anecortave acetate can slow or stop the progression of age-related macular degeneration in patients who do not qualify for other studies and have no ot...
Detailed Description
Choroidal neovascularization (CNV), a complication of age-related macular degeneration (AMD), is the most common cause of profound visual loss in the United States. Laser photocoagulation has been sho...
Eligibility Criteria
Inclusion
- Choroidal neovascularization, mostly occult
- Visual acuity \> 20/40 in study eye
Exclusion
- Allergy to fluorescein dye
- Inability to stop warfarin prior to treatment
- Pregnancy
- Other serious ocular diseases or conditions
Key Trial Info
Start Date :
January 1 2003
Trial Type :
EXPANDED_ACCESS
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00349739
Start Date
January 1 2003
End Date
August 1 2008
Last Update
January 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals and Clinics, Ophthalmology
Iowa City, Iowa, United States, 52242